News for BriaCell Therapeutics Corp. (BCTXW)

Shares of Coursera, Inc. COUR rose sharply in today's pre-market trading after the company reported better-than-expected first-quarter financial results. Cours...

BriaCell Therapeutics (BCTX) will present four clinical data presentations at the ASCO 2025 Annual Meeting in Chicago. The sessions include a Phase III

**media[602837]**

Shares of Vertiv Holdings Co VRT rose sharply in today's pre-market trading after the company reported better-than-expected first-quarter financial results and ...

Innovative Company has introduced a fresh offering of common units, a strategic move designed to boost its capital reserves. Each unit in this offering is compo

**media[601451]**

BriaCell Therapeutics Corp. (BCTX) has unveiled encouraging results from its Phase 2 clinical trial, showing that its Bria-IMT regimen, combined with checkpoint

**media[596675]**

BriaPro is developing novel antibodies to B7-H3, a key cancer antigen and immune checkpointHighly expressed on the cell surfaces of both tumor and immune cells,

**media[577145]**

The Data Safety Monitoring Board (DSMB) identified no safety concerns, and recommended continuation of BriaCell's pivotal Phase 3 study of Bria-IMTâ„¢ plus immu

Stocks Analysis by MarketBeat.com (Nathan Reiff) covering: Briacell Therapeutics Corp, Recursion Pharmaceuticals Inc. Read MarketBeat.com (Nathan Reiff)'s latest article on Investing.com

**media[533568]**

PHILADELPHIA, Pa. and VANCOUVER, British Columbia, Feb. 05, 2025 (GLOBE NEWSWIRE) —

Shares of Palantir Technologies Inc. PLTR rose sharply in today's pre-market trading following better-than-expected fourth-quarter results. Palantir reported f...

**media[531248]**

**media[531193]**

Lung metastasis (from metastatic breast cancer) resolved - after only 2 months (4 doses) of treatment with Bria-OTSâ„¢ monotherapyNo toxicity related to the tre

PHILADELPHIA and VANCOUVER, British Columbia, Jan. 27, 2025 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“